Emrok O Tablet

Emrok O Tablet belongs to the class of 'antibiotics', primarily used to treat bacterial skin and soft tissue infections, including diabetic foot infections and concurrent bacteraemia (presence of viable bacteria in the bloodstream). It also targets Methicillin-resistant Staphylococcus aureus (MRSA), which causes antimicrobial resistance (AMR). 

Emrok O Tablet contains 'Levonadifloxacin,' a bactericidal agent that prevents bacterial growth and interrupts bacterial replication. It is also a beta-lactamase inhibitor. Beta-lactamases are the enzymes produced by the bacteria that inactivate the antibiotic, leading to multi-resistance. Emrok O Tablet has a broad spectrum activity against various pathogens, including Methicillin-resistant Staphylococcus aureus (MRSA), which is a leading cause of rising antimicrobial resistance (AMR).

Take Emrok O Tablet as advised by a doctor. Emrok O Tablet may also cause side effects, although not everybody gets them. Common side effects of Emrok O Tablet include constipation, vomiting, and cough. These side effects do not require medical attention and gradually resolve over time. If these side effects persist longer, please consult your doctor.

Brief your medical history to the doctor if you are allergic to Emrok O Tablet or any of its components. Before starting this medicine, let your doctor know if you have any liver/kidney/heart diseases, diabetes, mental-health-related problems, myasthenia gravis (muscle weakness), tendon-related diseases or peripheral neuropathy (nerve damage). Emrok O Tablet should be used only with a doctor's advice during pregnancy and breastfeeding. Emrok O Tablet is not recommended in patients under 18 years of age.

Emrok O Tablet contains 'Levonadifloxacin,' a broad-spectrum anti-MRSA agent that treats bacterial skin and soft tissue infections, including diabetic foot infections and concurrent bacteraemia. It is a fl­uoroquinolone antibiotic and is bactericidal in action. It works by inhibiting beta-lactamase, the enzyme produced by the bacteria, which inactivates the antibiotic, leading to multi-resistance. 

Do not use Emrok O Tablet if you are allergic to Emrok O Tablet or its components. Inform your doctor if you have liver/kidney/heart diseases, diabetes, mental-health-related problems, myasthenia gravis, tendon-related diseases or peripheral neuropathy before starting Emrok O Tablet. Pregnant and breastfeeding should use this medicine only when a doctor has prescribed it. Avoid driving or operating machinery if you notice any dizziness, headache or visual disorders that may impair your ability to concentrate and react. Emrok O Tablet is not recommended in patients under 18 years of age.

• There is an increased risk of tendinitis and tendon rupture following fluoroquinolone (like Levonadifloxacin) therapy; hence a cautious use of Emrok O Tablet is recommended.
• Emrok O Tablet may cause mental health-related side effects; hence patients with mood disorders should take advice accordingly.
• Monitor your blood sugar levels regularly since Levonadifloxacin may affect your glucose levels in diabetes.
• Clostridium difficile-associated diarrhoea (CDAD) is reported during the usage of antibiotics. Please see your doctor if you experience prolonged diarrhoea.